Literature DB >> 35685263

A case of wearable defibrillator failure: How one lifesaving therapy delays another.

Lane Zhang1, Aditya Bhonsale1, Sandeep Jain1.   

Abstract

Use of a wearable cardiac defibrillator (WCD) is indicated for primary prevention of sudden cardiac death for patients ineligible for implantable cardioverter-defibrillators. While published reports of WCD rhythm detection algorithm demonstrate effective detection of ventricular tachycardia and ventricular fibrillation (VF), clinical studies show some patients wearing the WCD are not successfully resuscitated. We present a case of a patient who did not receive an appropriate shock while wearing a WCD despite the device's initial detection of VF. We hypothesize that the onset of bystander cardiopulmonary resuscitation was responsible for hindering the detection algorithm, ultimately canceling the appropriate rescue shock. <Learning objective: The purpose of this case is to draw attention to the possibility that a wearable cardiac defibrillator may not deliver life-saving shock therapy due to initiation of bystander cardiopulmonary resuscitation (CPR). During the detection window, it is possible for bystander CPR to create significant noise on the detection channels. This noise may cause the defibrillator to mis-interpret the arrhythmia as artifact and in turn inhibit life-saving therapy.>.
© 2021 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cardiac arrest; Failure; Wearable cardiac defibrillator

Year:  2021        PMID: 35685263      PMCID: PMC9168994          DOI: 10.1016/j.jccase.2021.12.003

Source DB:  PubMed          Journal:  J Cardiol Cases        ISSN: 1878-5409


  4 in total

1.  2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.

Authors:  Sana M Al-Khatib; William G Stevenson; Michael J Ackerman; William J Bryant; David J Callans; Anne B Curtis; Barbara J Deal; Timm Dickfeld; Michael E Field; Gregg C Fonarow; Anne M Gillis; Christopher B Granger; Stephen C Hammill; Mark A Hlatky; José A Joglar; G Neal Kay; Daniel D Matlock; Robert J Myerburg; Richard L Page
Journal:  Circulation       Date:  2018-09-25       Impact factor: 29.690

2.  Wearable Cardioverter-Defibrillator Therapy for the Prevention of Sudden Cardiac Death: A Systematic Review and Meta-Analysis.

Authors:  Ahmad Masri; Ahmed M Altibi; Sebhat Erqou; Mohammad A Zmaili; Ala Saleh; Raed Al-Adham; Karam Ayoub; Moaaz Baghal; Laith Alkukhun; Amr F Barakat; Sandeep Jain; Samir Saba; Evan Adelstein
Journal:  JACC Clin Electrophysiol       Date:  2019-01-30

3.  Wearable Cardioverter-Defibrillator after Myocardial Infarction.

Authors:  Jeffrey E Olgin; Mark J Pletcher; Eric Vittinghoff; Jerzy Wranicz; Rajesh Malik; Daniel P Morin; Steven Zweibel; Alfred E Buxton; Claude S Elayi; Eugene H Chung; Eric Rashba; Martin Borggrefe; Trisha F Hue; Carol Maguire; Feng Lin; Joel A Simon; Stephen Hulley; Byron K Lee
Journal:  N Engl J Med       Date:  2018-09-27       Impact factor: 91.245

4.  Impact of wearable cardioverter-defibrillator compliance on outcomes in the VEST trial: As-treated and per-protocol analyses.

Authors:  Jeffrey E Olgin; Byron K Lee; Eric Vittinghoff; Daniel P Morin; Steven Zweibel; Eric Rashba; Eugene H Chung; Martin Borggrefe; Stephen Hulley; Feng Lin; Trisha F Hue; Mark J Pletcher
Journal:  J Cardiovasc Electrophysiol       Date:  2020-03-03       Impact factor: 2.942

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.